JHS Svendgaard Laboratories Limited (IN:JHS)
:JHS
JHS Stock Chart & Stats
₹9.34
₹0.02(0.10%)
At close: 4:00 PM EST
₹9.34
₹0.02(0.10%)
Day’s Range― - ―
52-Week Range₹6.15 - ₹16.20
Previous CloseN/A
Volume57.31K
Average Volume (3M)16.78K
Market Cap
₹696.82M
Enterprise Value₹616.52M
Total Cash (Recent Filing)₹200.11M
Total Debt (Recent Filing)₹105.87M
Price to Earnings (P/E)27.3
Beta0.93
Next Earnings
Jun 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.09
Shares Outstanding85,603,966
10 Day Avg. Volume16,348
30 Day Avg. Volume16,781
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)0.57
Price to Sales (P/S)1.06
P/FCF Ratio-6.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthA very high equity ratio and minimal financial leverage provide durable financial flexibility. This balance sheet strength helps absorb operational shocks, supports working-capital financing for manufacturing, and lowers refinancing risk while management addresses operating performance.
Contract Manufacturing ModelA contract-manufacturing, private-label model yields recurring, order-driven revenue and long-term customer relationships. Structural demand for oral/personal care supports stable volumes and allows focus on production efficiency rather than costly brand building.
Improving Gross MarginA notable uptick in gross margin signals better input cost control or improved product mix, indicating operational improvements that can sustain higher conversion of sales to gross profit. If maintained, this underpins future recovery in operating profitability.
Bears Say
Revenue DeclineSustained multi-year revenue erosion reduces scale and undermines fixed-cost absorption in a manufacturing business. Lower volumes pressure per-unit margins, limit pricing power with suppliers and customers, and constrain the firm's ability to leverage capacity for recovery.
Negative Free Cash FlowPersistent negative free cash flow limits reinvestment in maintenance capex, working capital and process improvements. Reliance on financing cash inflows is not a durable substitute and raises risk of underinvestment or liquidity strain during cyclical downturns.
Sustained UnprofitabilityExtended losses and negative operating margins erode retained capital and produce negative returns on equity despite a strong equity base. This constrains management's ability to fund growth, reduces strategic optionality, and may weaken supplier or customer confidence over time.
JHS Svendgaard Laboratories Limited News
JHS FAQ
What was JHS Svendgaard Laboratories Limited’s price range in the past 12 months?
JHS Svendgaard Laboratories Limited lowest stock price was ₹6.15 and its highest was ₹16.20 in the past 12 months.
What is JHS Svendgaard Laboratories Limited’s market cap?
JHS Svendgaard Laboratories Limited’s market cap is ₹696.82M.
When is JHS Svendgaard Laboratories Limited’s upcoming earnings report date?
JHS Svendgaard Laboratories Limited’s upcoming earnings report date is Jun 02, 2026 which is in 55 days.
How were JHS Svendgaard Laboratories Limited’s earnings last quarter?
JHS Svendgaard Laboratories Limited released its earnings results on Feb 10, 2026. The company reported ₹0.092 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.092.
Is JHS Svendgaard Laboratories Limited overvalued?
According to Wall Street analysts JHS Svendgaard Laboratories Limited’s price is currently Overvalued.
Does JHS Svendgaard Laboratories Limited pay dividends?
JHS Svendgaard Laboratories Limited pays a Annually dividend of ₹0.75 which represents an annual dividend yield of N/A. See more information on JHS Svendgaard Laboratories Limited dividends here
What is JHS Svendgaard Laboratories Limited’s EPS estimate?
JHS Svendgaard Laboratories Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does JHS Svendgaard Laboratories Limited have?
JHS Svendgaard Laboratories Limited has 85,603,966 shares outstanding.
What happened to JHS Svendgaard Laboratories Limited’s price movement after its last earnings report?
JHS Svendgaard Laboratories Limited reported an EPS of ₹0.092 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.965%.
Which hedge fund is a major shareholder of JHS Svendgaard Laboratories Limited?
Currently, no hedge funds are holding shares in IN:JHS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
JHS Svendgaard Laboratories Limited
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, hand sanitizers, laundry detergents, room fresheners, and denture products under the Dr. Gold and Aquawhite brands. It also provides contract manufacturing services for oral care products of other brands; and operates retail stores at airports. The company also exports its products. JHS Svendgaard Laboratories Limited was founded in 1996 and is based in New Delhi, India.
Technical Analysis
Grob Tea Co. Ltd.
―
Kovilpatti Lakshmi Roller Flour Mills Ltd
―
Mohini Health & Hygiene Ltd.
―
Nagreeka Exports Ltd
―
Priti International Ltd.
―